PTGS2 and Opportunistic infection: Of particular significance are data that found that treatment with either the selective COX-2 inhibitor NS398 or the broad acting COX inhibitor indomethacin improved survival rates in mice subjected to trauma and infectious challenge (31, 32), and lowered the rates of early opportunistic infections in patients undergoing major surgery (86).